Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC

Abroad (travel likely)RecruitingPHASE3

Conditions

Non Small Cell Lung Cancer Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Clínica Viedma, Viedma, Río Negro Province, Argentina
Contact: Study coordinator (Marcelo Guthmann, PhD) · marcelo.guthmann@elea.com

Study leads

Eduardo Spitzer, MSc
Study Chair
Laboratorio Elea Phoenix

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Advanced or Metastatic Solid Tumors · Non Small Cell Lung Cancer · NSCLC

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · New Haven, United States

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Pancreatic Ductal Adenocarcinoma · Non Small Cell Lung Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Baltimore, United States

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Miami, United States · Basking Ridge, United States